Smithfield Trust’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-325
Closed -$7K 1081
2021
Q3
$7K Hold
325
﹤0.01% 925
2021
Q2
$6K Hold
325
﹤0.01% 947
2021
Q1
$7K Hold
325
﹤0.01% 928
2020
Q4
$7K Hold
325
﹤0.01% 902
2020
Q3
$8K Sell
325
-345
-51% -$8.05K ﹤0.01% 811
2020
Q2
$16K Hold
670
﹤0.01% 656
2020
Q1
$12K Buy
+670
New +$12.3K ﹤0.01% 646

Other funds holding EXEL

Smithfield Trust's EXEL Position: Q4 2021 in Review

Smithfield Trust sold out of Exelixis (EXEL) in Q4 2021, closing a stake of 325 shares — an estimated $7K sold.

Smithfield Trust first reported a position in EXEL in Q1 2020 and held it in 7 quarters. The position peaked at $16K in Q2 2020. 328 funds tracked by Wall St. Rank hold EXEL as of Q4 2021.

  • Smithfield Trust reported no remaining Exelixis position as of Q4 2021 after selling out during the quarter.
  • Smithfield Trust sold 325 Exelixis shares in Q4 2021, an estimated $7K.
  • Smithfield Trust first reported a position in Exelixis in Q1 2020 and held it in 7 quarters.
  • Smithfield Trust's Exelixis position peaked at $16K in Q2 2020.
  • 328 funds tracked by Wall St. Rank held Exelixis as of Q4 2021.

Based on Smithfield Trust's 13F filing for Q4 2021, filed 14 Feb 2022.